Serum HER2 levels predict treatment efficacy and prognosis in patients with HER2-positive breast cancer undergoing neoadjuvant treatment

BACKGROUND: Controversy remains regarding the predictive and prognostic value of serum human epidermal growth factor receptor 2 (HER2) in breast cancer. The purpose of this retrospective study was to determine the clinical utility and efficacy of serum HER2 (sHER2) in predicting treatment response a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Gland Surg
Main Authors: Zuo, Wen-Jia, He, Min, Zheng, Hui, Liu, Yin, Liu, Xi-Yu, Jiang, Yi-Zhou, Wang, Zhong-Hua, Lu, Ren-Quan, Shao, Zhi-Ming
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8102211/
https://ncbi.nlm.nih.gov/pubmed/33968682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/gs-20-802
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados